![[Experimental]](figures/lifecycle-experimental.svg)
Create listings displaying key_cols and disp_cols to produce a compact and
elegant representation of the input data.frame or tibble.
Usage
as_listing(
df,
key_cols = names(df)[1],
disp_cols = NULL,
non_disp_cols = NULL,
unique_rows = FALSE,
default_formatting = list(all = fmt_config()),
col_formatting = NULL,
main_title = NULL,
subtitles = NULL,
main_footer = NULL,
prov_footer = NULL,
split_into_pages_by_var = NULL
)
as_keycol(vec)
is_keycol(vec)
get_keycols(df)
listing_dispcols(df)
add_listing_dispcol(df, new)
listing_dispcols(df) <- value
add_listing_col(
df,
name,
fun = NULL,
format = NULL,
na_str = "NA",
align = "left"
)Arguments
- df
(
data.frameorlisting_df)
thedata.frameto be converted to a listing orlisting_dfto be modified.- key_cols
(
character)
vector of names of columns which should be treated as key columns when rendering the listing. Key columns allow you to group repeat occurrences.- disp_cols
(
characterorNULL)
vector of names of non-key columns which should be displayed when the listing is rendered. Defaults to all columns ofdfnot named inkey_colsornon_disp_cols.- non_disp_cols
(
characterorNULL)
vector of names of non-key columns to be excluded as display columns. All other non-key columns are treated as display columns. Ignored ifdisp_colsis non-NULL.- unique_rows
(
flag)
whether only unique rows should be included in the listing. Defaults toFALSE.- default_formatting
(
list)
a named list of default column format configurations to apply when rendering the listing. Each name-value pair consists of a name corresponding to a data class (or "numeric" for all unspecified numeric classes) and a value of typefmt_configwith the format configuration that should be implemented for columns of that class. If named element "all" is included in the list, this configuration will be used for all data classes not specified. Objects of typefmt_configcan take 3 arguments:format,na_str, andalign.- col_formatting
(
list)
a named list of custom column formatting configurations to apply to specific columns when rendering the listing. Each name-value pair consists of a name corresponding to a column name and a value of typefmt_configwith the formatting configuration that should be implemented for that column. Objects of typefmt_configcan take 3 arguments:format,na_str, andalign. Defaults toNULL.- main_title
(
stringorNULL)
the main title for the listing, orNULL(the default).- subtitles
(
characterorNULL)
a vector of subtitles for the listing, orNULL(the default).(
characterorNULL)
a vector of main footer lines for the listing, orNULL(the default).(
characterorNULL)
a vector of provenance footer lines for the listing, orNULL(the default). Each string element is placed on a new line.- split_into_pages_by_var
(
characterorNULL)
the name of a variable for on the listing should be split into pages, with each page corresponding to one unique value/level of the variable. Seesplit_into_pages_by_var()for more details.- vec
(
string)
name of a column vector from alisting_dfobject to be annotated as a key column.- new
(
character)
vector of names of columns to be added to the set of display columns.- value
(
string)
new value.- name
(
string)
name of the existing or new column to be displayed when the listing is rendered.- fun
(
functionorNULL)
a function which acceptsdfand returns the vector for a new column, which is added todfasname, orNULLif marking an existing column as a listing column.- format
(
stringorfunction)
a format label (string) or formatter function.- na_str
(
string)
string that should be displayed in place of missing values.- align
(
string)
alignment values should be rendered with.
Value
A listing_df object, sorted by its key columns.
df with name created (if necessary) and marked for
display during rendering.
Details
At its core, a listing_df object is a tbl_df object with a customized
print method and support for the formatting and pagination machinery provided by
the formatters package.
listing_df objects have two 'special' types of columns: key columns and display columns.
Key columns act as indexes, which means a number of things in practice.
All key columns are also display columns.
listing_df objects are always sorted by their set of key columns at creation time.
Any listing_df object which is not sorted by its full set of key columns (e.g.,
one whose rows have been reordered explicitly during creation) is invalid and the behavior
when rendering or paginating that object is undefined.
Each value of a key column is printed only once per page and per unique combination of values for all higher-priority (i.e., to the left of it) key columns. Locations where a repeated value would have been printed within a key column for the same higher-priority-key combination on the same page are rendered as empty space. Note, determination of which elements to display within a key column at rendering is based on the underlying value; any non-default formatting applied to the column has no effect on this behavior.
Display columns are columns which should be rendered, but are not key columns. By default this is all non-key columns in the incoming data, but in need not be. Columns in the underlying data which are neither key nor display columns remain within the object available for computations but are not rendered during printing or export of the listing.
Examples
dat <- ex_adae
# This example demonstrates the listing with key_cols (values are grouped by USUBJID) and
# multiple lines in prov_footer
lsting <- as_listing(dat[1:25, ],
key_cols = c("USUBJID", "AESOC"),
main_title = "Example Title for Listing",
subtitles = "This is the subtitle for this Adverse Events Table",
main_footer = "Main footer for the listing",
prov_footer = c(
"You can even add a subfooter", "Second element is place on a new line",
"Third string"
)
) %>%
add_listing_col("AETOXGR") %>%
add_listing_col("BMRKR1", format = "xx.x") %>%
add_listing_col("AESER / AREL", fun = function(df) paste(df$AESER, df$AREL, sep = " / "))
mat <- matrix_form(lsting)
cat(toString(mat))
#> Example Title for Listing
#> This is the subtitle for this Adverse Events Table
#>
#> —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
#> Unique Subject Identifier Primary System Organ Class Study Identifier Subject Identifier for the Study Study Site Identifier Age Sex Race Country Investigator Identifier Description of Planned Arm Planned Arm Code Description of Actual Arm Actual Arm Code Stratification Factor 1 Stratification Factor 2 Continous Level Biomarker 1 Categorical Level Biomarker 2 Intent-To-Treat Population Flag Safety Population Flag Response Evaluable Population Flag Biomarker Evaluable Population Flag Date of Randomization Datetime of First Exposure to Treatment Datetime of Last Exposure to Treatment End of Study Status End of Study Date End of Study Relative Day Reason for Discontinuation from Study Date of Death Date Last Known Alive NOT A STANDARD BUT NEEDED FOR RCD Analysis Sequence Number Sponsor-Defined Identifier Reported Term for the Adverse Event Lowest Level Term Dictionary-Derived Term High Level Term High Level Group Term Body System or Organ Class Severity/Intensity Serious Event Analysis Causality Analysis Start Datetime Analysis End Datetime Analysis Start Relative Day Analysis End Relative Day Analysis Toxicity Grade AESER / AREL
#> —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
#> AB12345-BRA-1-id-134 cl A AB12345 id-134 BRA-1 47 M WHITE BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S2 6.5 LOW Y Y Y N 2021-06-09 2021-06-10 13:26:53.956201 2023-06-11 01:05:17.956201 COMPLETED 2023-06-11 731 NA 2023-06-11 2023-06-29 63113904 3 3 trm A.1.1.1.2 llt A.1.1.1.2 dcd A.1.1.1.2 hlt A.1.1.1 hlgt A.1.1 cl A.1 MODERATE Y N 2022-10-20 2023-06-05 497 725 2 Y / N
#> AB12345 id-134 BRA-1 47 M WHITE BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S2 6.5 LOW Y Y Y N 2021-06-09 2021-06-10 13:26:53.956201 2023-06-11 01:05:17.956201 COMPLETED 2023-06-11 731 NA 2023-06-11 2023-06-29 63113904 4 4 trm A.1.1.1.2 llt A.1.1.1.2 dcd A.1.1.1.2 hlt A.1.1.1 hlgt A.1.1 cl A.1 MODERATE Y N 2023-02-08 2023-04-15 608 674 2 Y / N
#> cl B AB12345 id-134 BRA-1 47 M WHITE BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S2 6.5 LOW Y Y Y N 2021-06-09 2021-06-10 13:26:53.956201 2023-06-11 01:05:17.956201 COMPLETED 2023-06-11 731 NA 2023-06-11 2023-06-29 63113904 1 1 trm B.2.1.2.1 llt B.2.1.2.1 dcd B.2.1.2.1 hlt B.2.1.2 hlgt B.2.1 cl B.2 MODERATE N N 2022-02-16 2022-11-10 251 518 3 N / N
#> cl D AB12345 id-134 BRA-1 47 M WHITE BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S2 6.5 LOW Y Y Y N 2021-06-09 2021-06-10 13:26:53.956201 2023-06-11 01:05:17.956201 COMPLETED 2023-06-11 731 NA 2023-06-11 2023-06-29 63113904 2 2 trm D.1.1.4.2 llt D.1.1.4.2 dcd D.1.1.4.2 hlt D.1.1.4 hlgt D.1.1 cl D.1 MODERATE N N 2022-04-10 2022-12-21 304 559 3 N / N
#> AB12345-BRA-1-id-141 cl A AB12345 id-141 BRA-1 35 F WHITE BRA BRA-1 C: Combination ARM C C: Combination ARM C B S1 7.5 HIGH Y Y Y Y 2021-02-25 2021-02-28 23:47:16.956201 2023-03-01 11:25:40.956201 COMPLETED 2023-03-01 731 NA 2023-03-01 2023-03-30 63113904 3 3 trm A.1.1.1.1 llt A.1.1.1.1 dcd A.1.1.1.1 hlt A.1.1.1 hlgt A.1.1 cl A.1 MILD N N 2022-07-06 2022-07-29 493 516 1 N / N
#> AB12345 id-141 BRA-1 35 F WHITE BRA BRA-1 C: Combination ARM C C: Combination ARM C B S1 7.5 HIGH Y Y Y Y 2021-02-25 2021-02-28 23:47:16.956201 2023-03-01 11:25:40.956201 COMPLETED 2023-03-01 731 NA 2023-03-01 2023-03-30 63113904 4 4 trm A.1.1.1.2 llt A.1.1.1.2 dcd A.1.1.1.2 hlt A.1.1.1 hlgt A.1.1 cl A.1 MODERATE Y N 2022-10-21 2023-01-22 600 693 2 Y / N
#> AB12345 id-141 BRA-1 35 F WHITE BRA BRA-1 C: Combination ARM C C: Combination ARM C B S1 7.5 HIGH Y Y Y Y 2021-02-25 2021-02-28 23:47:16.956201 2023-03-01 11:25:40.956201 COMPLETED 2023-03-01 731 NA 2023-03-01 2023-03-30 63113904 5 5 trm A.1.1.1.1 llt A.1.1.1.1 dcd A.1.1.1.1 hlt A.1.1.1 hlgt A.1.1 cl A.1 MILD N N 2022-11-25 2023-01-07 635 678 1 N / N
#> cl B AB12345 id-141 BRA-1 35 F WHITE BRA BRA-1 C: Combination ARM C C: Combination ARM C B S1 7.5 HIGH Y Y Y Y 2021-02-25 2021-02-28 23:47:16.956201 2023-03-01 11:25:40.956201 COMPLETED 2023-03-01 731 NA 2023-03-01 2023-03-30 63113904 1 1 trm B.2.1.2.1 llt B.2.1.2.1 dcd B.2.1.2.1 hlt B.2.1.2 hlgt B.2.1 cl B.2 MODERATE N N 2021-11-14 2021-11-21 259 266 3 N / N
#> cl D AB12345 id-141 BRA-1 35 F WHITE BRA BRA-1 C: Combination ARM C C: Combination ARM C B S1 7.5 HIGH Y Y Y Y 2021-02-25 2021-02-28 23:47:16.956201 2023-03-01 11:25:40.956201 COMPLETED 2023-03-01 731 NA 2023-03-01 2023-03-30 63113904 2 2 trm D.2.1.5.3 llt D.2.1.5.3 dcd D.2.1.5.3 hlt D.2.1.5 hlgt D.2.1 cl D.2 MILD N Y 2021-12-28 2023-02-21 303 723 1 N / Y
#> AB12345 id-141 BRA-1 35 F WHITE BRA BRA-1 C: Combination ARM C C: Combination ARM C B S1 7.5 HIGH Y Y Y Y 2021-02-25 2021-02-28 23:47:16.956201 2023-03-01 11:25:40.956201 COMPLETED 2023-03-01 731 NA 2023-03-01 2023-03-30 63113904 6 6 trm D.1.1.1.1 llt D.1.1.1.1 dcd D.1.1.1.1 hlt D.1.1.1 hlgt D.1.1 cl D.1 SEVERE Y N 2023-02-28 2023-03-01 730 731 5 Y / N
#> AB12345-BRA-1-id-236 cl B AB12345 id-236 BRA-1 32 M BLACK OR AFRICAN AMERICAN BRA BRA-1 B: Placebo ARM B B: Placebo ARM B A S2 7.7 HIGH Y Y Y Y 2021-08-17 2021-08-21 18:13:25.956201 2023-08-22 05:51:49.956201 COMPLETED 2023-08-22 731 NA 2023-08-22 2023-09-14 63113904 1 1 trm B.1.1.1.1 llt B.1.1.1.1 dcd B.1.1.1.1 hlt B.1.1.1 hlgt B.1.1 cl B.1 SEVERE N Y 2021-09-12 2022-10-27 22 432 5 N / Y
#> AB12345 id-236 BRA-1 32 M BLACK OR AFRICAN AMERICAN BRA BRA-1 B: Placebo ARM B B: Placebo ARM B A S2 7.7 HIGH Y Y Y Y 2021-08-17 2021-08-21 18:13:25.956201 2023-08-22 05:51:49.956201 COMPLETED 2023-08-22 731 NA 2023-08-22 2023-09-14 63113904 2 2 trm B.1.1.1.1 llt B.1.1.1.1 dcd B.1.1.1.1 hlt B.1.1.1 hlgt B.1.1 cl B.1 SEVERE N Y 2022-02-18 2023-07-20 181 698 5 N / Y
#> AB12345 id-236 BRA-1 32 M BLACK OR AFRICAN AMERICAN BRA BRA-1 B: Placebo ARM B B: Placebo ARM B A S2 7.7 HIGH Y Y Y Y 2021-08-17 2021-08-21 18:13:25.956201 2023-08-22 05:51:49.956201 COMPLETED 2023-08-22 731 NA 2023-08-22 2023-09-14 63113904 3 3 trm B.1.1.1.1 llt B.1.1.1.1 dcd B.1.1.1.1 hlt B.1.1.1 hlgt B.1.1 cl B.1 SEVERE N Y 2023-07-24 2023-07-28 702 706 5 N / Y
#> AB12345-BRA-1-id-265 cl C AB12345 id-265 BRA-1 25 M WHITE BRA BRA-1 C: Combination ARM C C: Combination ARM C A S2 10.3 MEDIUM Y Y Y N 2020-05-09 2020-05-13 00:38:12.956201 2021-09-18 15:23:35.956201 DISCONTINUED 2021-09-18 494 WITHDRAWAL BY PARENT/GUARDIAN 2021-09-18 2021-10-08 63113904 1 1 trm C.2.1.2.1 llt C.2.1.2.1 dcd C.2.1.2.1 hlt C.2.1.2 hlgt C.2.1 cl C.2 MODERATE N Y 2020-06-30 2020-08-13 48 92 2 N / Y
#> AB12345 id-265 BRA-1 25 M WHITE BRA BRA-1 C: Combination ARM C C: Combination ARM C A S2 10.3 MEDIUM Y Y Y N 2020-05-09 2020-05-13 00:38:12.956201 2021-09-18 15:23:35.956201 DISCONTINUED 2021-09-18 494 WITHDRAWAL BY PARENT/GUARDIAN 2021-09-18 2021-10-08 63113904 4 4 trm C.1.1.1.3 llt C.1.1.1.3 dcd C.1.1.1.3 hlt C.1.1.1 hlgt C.1.1 cl C.1 SEVERE N Y 2021-06-20 2021-07-27 403 440 4 N / Y
#> cl D AB12345 id-265 BRA-1 25 M WHITE BRA BRA-1 C: Combination ARM C C: Combination ARM C A S2 10.3 MEDIUM Y Y Y N 2020-05-09 2020-05-13 00:38:12.956201 2021-09-18 15:23:35.956201 DISCONTINUED 2021-09-18 494 WITHDRAWAL BY PARENT/GUARDIAN 2021-09-18 2021-10-08 63113904 2 2 trm D.1.1.4.2 llt D.1.1.4.2 dcd D.1.1.4.2 hlt D.1.1.4 hlgt D.1.1 cl D.1 MODERATE N N 2020-11-29 2021-05-10 200 362 3 N / N
#> AB12345 id-265 BRA-1 25 M WHITE BRA BRA-1 C: Combination ARM C C: Combination ARM C A S2 10.3 MEDIUM Y Y Y N 2020-05-09 2020-05-13 00:38:12.956201 2021-09-18 15:23:35.956201 DISCONTINUED 2021-09-18 494 WITHDRAWAL BY PARENT/GUARDIAN 2021-09-18 2021-10-08 63113904 3 3 trm D.1.1.1.1 llt D.1.1.1.1 dcd D.1.1.1.1 hlt D.1.1.1 hlgt D.1.1 cl D.1 SEVERE Y N 2021-06-09 2021-06-30 392 413 5 Y / N
#> AB12345-BRA-1-id-42 cl A AB12345 id-42 BRA-1 36 M BLACK OR AFRICAN AMERICAN BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S1 2.3 MEDIUM Y Y Y Y 2020-08-06 2020-08-07 06:44:59.956201 NA ONGOING NA NA NA NA NA 63113904 4 4 trm A.1.1.1.2 llt A.1.1.1.2 dcd A.1.1.1.2 hlt A.1.1.1 hlgt A.1.1 cl A.1 MODERATE Y N 2021-01-14 2021-09-30 160 419 2 Y / N
#> AB12345 id-42 BRA-1 36 M BLACK OR AFRICAN AMERICAN BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S1 2.3 MEDIUM Y Y Y Y 2020-08-06 2020-08-07 06:44:59.956201 NA ONGOING NA NA NA NA NA 63113904 6 6 trm A.1.1.1.2 llt A.1.1.1.2 dcd A.1.1.1.2 hlt A.1.1.1 hlgt A.1.1 cl A.1 MODERATE Y N 2021-11-10 2022-05-23 460 654 2 Y / N
#> AB12345 id-42 BRA-1 36 M BLACK OR AFRICAN AMERICAN BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S1 2.3 MEDIUM Y Y Y Y 2020-08-06 2020-08-07 06:44:59.956201 NA ONGOING NA NA NA NA NA 63113904 8 8 trm A.1.1.1.2 llt A.1.1.1.2 dcd A.1.1.1.2 hlt A.1.1.1 hlgt A.1.1 cl A.1 MODERATE Y N 2021-11-26 2022-03-18 476 588 2 Y / N
#> cl B AB12345 id-42 BRA-1 36 M BLACK OR AFRICAN AMERICAN BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S1 2.3 MEDIUM Y Y Y Y 2020-08-06 2020-08-07 06:44:59.956201 NA ONGOING NA NA NA NA NA 63113904 5 5 trm B.2.2.3.1 llt B.2.2.3.1 dcd B.2.2.3.1 hlt B.2.2.3 hlgt B.2.2 cl B.2 MILD Y N 2021-05-26 2021-07-15 292 342 1 Y / N
#> AB12345 id-42 BRA-1 36 M BLACK OR AFRICAN AMERICAN BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S1 2.3 MEDIUM Y Y Y Y 2020-08-06 2020-08-07 06:44:59.956201 NA ONGOING NA NA NA NA NA 63113904 7 7 trm B.1.1.1.1 llt B.1.1.1.1 dcd B.1.1.1.1 hlt B.1.1.1 hlgt B.1.1 cl B.1 SEVERE N Y 2021-11-20 2022-03-30 470 600 5 N / Y
#> cl C AB12345 id-42 BRA-1 36 M BLACK OR AFRICAN AMERICAN BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S1 2.3 MEDIUM Y Y Y Y 2020-08-06 2020-08-07 06:44:59.956201 NA ONGOING NA NA NA NA NA 63113904 1 1 trm C.2.1.2.1 llt C.2.1.2.1 dcd C.2.1.2.1 hlt C.2.1.2 hlgt C.2.1 cl C.2 MODERATE N Y 2020-09-15 2022-02-03 39 545 2 N / Y
#> AB12345 id-42 BRA-1 36 M BLACK OR AFRICAN AMERICAN BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S1 2.3 MEDIUM Y Y Y Y 2020-08-06 2020-08-07 06:44:59.956201 NA ONGOING NA NA NA NA NA 63113904 3 3 trm C.2.1.2.1 llt C.2.1.2.1 dcd C.2.1.2.1 hlt C.2.1.2 hlgt C.2.1 cl C.2 MODERATE N Y 2020-11-10 2021-09-12 95 401 2 N / Y
#> cl D AB12345 id-42 BRA-1 36 M BLACK OR AFRICAN AMERICAN BRA BRA-1 A: Drug X ARM A A: Drug X ARM A B S1 2.3 MEDIUM Y Y Y Y 2020-08-06 2020-08-07 06:44:59.956201 NA ONGOING NA NA NA NA NA 63113904 2 2 trm D.1.1.1.1 llt D.1.1.1.1 dcd D.1.1.1.1 hlt D.1.1.1 hlgt D.1.1 cl D.1 SEVERE Y N 2020-10-11 2022-07-02 65 694 5 Y / N
#> —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
#>
#> Main footer for the listing
#>
#> You can even add a subfooter
#> Second element is place on a new line
#> Third string
# This example demonstrates the listing table without key_cols
# and specifying the cols with disp_cols.
dat <- ex_adae
lsting <- as_listing(dat[1:25, ],
disp_cols = c("USUBJID", "AESOC", "RACE", "AETOXGR", "BMRKR1")
)
mat <- matrix_form(lsting)
cat(toString(mat))
#> Study Identifier Unique Subject Identifier Primary System Organ Class Race Analysis Toxicity Grade Continous Level Biomarker 1
#> —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
#> AB12345 AB12345-BRA-1-id-134 cl B WHITE 3 6.46299057842479
#> AB12345-BRA-1-id-134 cl D WHITE 3 6.46299057842479
#> AB12345-BRA-1-id-134 cl A WHITE 2 6.46299057842479
#> AB12345-BRA-1-id-134 cl A WHITE 2 6.46299057842479
#> AB12345-BRA-1-id-141 cl B WHITE 3 7.51607612428241
#> AB12345-BRA-1-id-141 cl D WHITE 1 7.51607612428241
#> AB12345-BRA-1-id-141 cl A WHITE 1 7.51607612428241
#> AB12345-BRA-1-id-141 cl A WHITE 2 7.51607612428241
#> AB12345-BRA-1-id-141 cl A WHITE 1 7.51607612428241
#> AB12345-BRA-1-id-141 cl D WHITE 5 7.51607612428241
#> AB12345-BRA-1-id-236 cl B BLACK OR AFRICAN AMERICAN 5 7.66300121077566
#> AB12345-BRA-1-id-236 cl B BLACK OR AFRICAN AMERICAN 5 7.66300121077566
#> AB12345-BRA-1-id-236 cl B BLACK OR AFRICAN AMERICAN 5 7.66300121077566
#> AB12345-BRA-1-id-265 cl C WHITE 2 10.323346349886
#> AB12345-BRA-1-id-265 cl D WHITE 3 10.323346349886
#> AB12345-BRA-1-id-265 cl D WHITE 5 10.323346349886
#> AB12345-BRA-1-id-265 cl C WHITE 4 10.323346349886
#> AB12345-BRA-1-id-42 cl C BLACK OR AFRICAN AMERICAN 2 2.26753940777848
#> AB12345-BRA-1-id-42 cl D BLACK OR AFRICAN AMERICAN 5 2.26753940777848
#> AB12345-BRA-1-id-42 cl C BLACK OR AFRICAN AMERICAN 2 2.26753940777848
#> AB12345-BRA-1-id-42 cl A BLACK OR AFRICAN AMERICAN 2 2.26753940777848
#> AB12345-BRA-1-id-42 cl B BLACK OR AFRICAN AMERICAN 1 2.26753940777848
#> AB12345-BRA-1-id-42 cl A BLACK OR AFRICAN AMERICAN 2 2.26753940777848
#> AB12345-BRA-1-id-42 cl B BLACK OR AFRICAN AMERICAN 5 2.26753940777848
#> AB12345-BRA-1-id-42 cl A BLACK OR AFRICAN AMERICAN 2 2.26753940777848
# This example demonstrates a listing with format configurations specified
# via the default_formatting and col_formatting arguments
dat <- ex_adae
dat$AENDY[3:6] <- NA
lsting <- as_listing(dat[1:25, ],
key_cols = c("USUBJID", "AESOC"),
disp_cols = c("STUDYID", "SEX", "ASEQ", "RANDDT", "ASTDY", "AENDY"),
default_formatting = list(
all = fmt_config(align = "left"),
numeric = fmt_config(
format = "xx.xx",
na_str = "<No data>",
align = "right"
)
)
) %>%
add_listing_col("BMRKR1", format = "xx.x", align = "center")
mat <- matrix_form(lsting)
cat(toString(mat))
#> Unique Subject Identifier Primary System Organ Class Study Identifier Sex Analysis Sequence Number Date of Randomization Analysis Start Relative Day Analysis End Relative Day Continous Level Biomarker 1
#> ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
#> AB12345-BRA-1-id-134 cl A AB12345 M 3.00 2021-06-09 497.00 <No data> 6.5
#> AB12345 M 4.00 2021-06-09 608.00 <No data> 6.5
#> cl B AB12345 M 1.00 2021-06-09 251.00 518.00 6.5
#> cl D AB12345 M 2.00 2021-06-09 304.00 559.00 6.5
#> AB12345-BRA-1-id-141 cl A AB12345 F 3.00 2021-02-25 493.00 516.00 7.5
#> AB12345 F 4.00 2021-02-25 600.00 693.00 7.5
#> AB12345 F 5.00 2021-02-25 635.00 678.00 7.5
#> cl B AB12345 F 1.00 2021-02-25 259.00 <No data> 7.5
#> cl D AB12345 F 2.00 2021-02-25 303.00 <No data> 7.5
#> AB12345 F 6.00 2021-02-25 730.00 731.00 7.5
#> AB12345-BRA-1-id-236 cl B AB12345 M 1.00 2021-08-17 22.00 432.00 7.7
#> AB12345 M 2.00 2021-08-17 181.00 698.00 7.7
#> AB12345 M 3.00 2021-08-17 702.00 706.00 7.7
#> AB12345-BRA-1-id-265 cl C AB12345 M 1.00 2020-05-09 48.00 92.00 10.3
#> AB12345 M 4.00 2020-05-09 403.00 440.00 10.3
#> cl D AB12345 M 2.00 2020-05-09 200.00 362.00 10.3
#> AB12345 M 3.00 2020-05-09 392.00 413.00 10.3
#> AB12345-BRA-1-id-42 cl A AB12345 M 4.00 2020-08-06 160.00 419.00 2.3
#> AB12345 M 6.00 2020-08-06 460.00 654.00 2.3
#> AB12345 M 8.00 2020-08-06 476.00 588.00 2.3
#> cl B AB12345 M 5.00 2020-08-06 292.00 342.00 2.3
#> AB12345 M 7.00 2020-08-06 470.00 600.00 2.3
#> cl C AB12345 M 1.00 2020-08-06 39.00 545.00 2.3
#> AB12345 M 3.00 2020-08-06 95.00 401.00 2.3
#> cl D AB12345 M 2.00 2020-08-06 65.00 694.00 2.3